Clinical predictors of asthmatics in identifying subgroup requiring long-term tiotropium add-on therapy: a real-world study

BACKGROUND: According to several phase III studies, tiotropium [a long-acting muscarinic antagonist (LAMA)] is a well-tolerated add-on therapy to inhaled corticosteroids (ICS) for asthmatics with or without the addition of long-acting beta2-agonists (LABAs). However, real-world studies based on clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Cheng, Wen-Chien, Liao, Wei-Chih, Wu, Biing-Ru, Chen, Chih-Yu, Shen, Meng-Fang, Chen, Wei-Chun, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Chia-Hung, Hsu, Wu-Huei
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790467/
https://ncbi.nlm.nih.gov/pubmed/31656651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.22
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados